An omic and multidimensional spatial atlas from serial biopsies of an evolving metastatic breast cancer - ScienceDirect
Human Cytokeratin 19 Antibody MAB35061-100: R&D Systems
![Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker KO Tested (ab7754)](https://www.abcam.com/ps/products/7/ab7754/reviews/images/ab7754_19313.jpg "Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker KO Tested (ab7754)")
Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker KO Tested (ab7754)
Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression” | bioRxiv
Pathology Outlines - Cytokeratin 19 (CK19, K19)
)---IHC-Prediluted-Immunohistochemistry-Paraffin-NBP2-48300-img0002.jpg "Cytokeratin, pan Antibody (PAN-CK (Cocktail)) - IHC-Prediluted (NBP2-48300): Novus Biologicals")
Cytokeratin, pan Antibody (PAN-CK (Cocktail)) - IHC-Prediluted (NBP2-48300): Novus Biologicals
A framework for multiplex imaging optimization and reproducible analysis | Communications Biology
Other Considerations and Issues in Pediatric Hepatology (Section V) - Liver Disease in Children
Toward reproducible, scalable, and robust data analysis across multiplex tissue imaging platforms - ScienceDirect
Effects of MeHg exposure (40 μg/kg BW/day) during pregnancy and... | Download Scientific Diagram
Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression” | bioRxiv
Tumors of the lung and mediastinum (Chapter 4) - Modern Immunohistochemistry
Keratin 19 Antibody BA17 | V3137 NSJ Bioreagents
Calcium channel blockers potentiate gemcitabine chemotherapy in pancreatic cancer | PNAS
![Anti-Cytokeratin 19 抗体 [A53-B/A2] - Cytoskeleton Marker (ab7754)](https://www.abcam.co.jp/ps/products/7/ab7754/Images/ab7754-396215-antiKRT19antibodyimmunocytochemistryimmunofluoresencemcf7human.jpg "Anti-Cytokeratin 19 抗体 [A53-B/A2] - Cytoskeleton Marker (ab7754)")
Anti-Cytokeratin 19 抗体 [A53-B/A2] - Cytoskeleton Marker (ab7754)
Calcium channel blockers potentiate gemcitabine chemotherapy in pancreatic cancer | PNAS
![Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker KO Tested (ab7754)](https://www.abcam.com/ps/products/308/ab308263/Images/ab308263-1-anti-pan-cytokeratin-antibody-epr28285-45-western-blot-a431-human-epidermoid-carcinoma-epithelial-cell-whole-cell-lysate-20-ug.jpg "Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker KO Tested (ab7754)")
Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker KO Tested (ab7754)
Human Cytokeratin 19 Antibody AF3506: R&D Systems
Toward reproducible, scalable, and robust data analysis across multiplex tissue imaging platforms - ScienceDirect
Human Cytokeratin 19 Antibody AF3506: R&D Systems
Human Cytokeratin 19 Alexa Fluor® 488-conjugated Antibody IC3506G: R&D Systems
![Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker KO Tested (ab7754)](https://www.abcam.com/ps/products/7/ab7754/Images/ab7754-472368-AntiCytokeratin19antibodyA53BA2immunohistochemistryliverhuman.jpg "Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker KO Tested (ab7754)")
Anti-Cytokeratin 19 antibody [A53-B/A2] - Cytoskeleton Marker KO Tested (ab7754)
Pathology Outlines - Cytokeratin 19 (CK19, K19)
-Immunohistochemistry-Paraffin-NBP2-44829-img0006.jpg "Cytokeratin 19 Antibody (KRT19/799 + KRT19/800) (NBP2-44829): Novus Biologicals")
Cytokeratin 19 Antibody (KRT19/799 + KRT19/800) (NBP2-44829): Novus Biologicals
Human Cytokeratin 19 Antibody MAB35061-100: R&D Systems
